Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction

Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction

Midori Shimada,1,2 Minoru Fukuda,2,3 Masaaki Fukuda,2 Takeshi Kitazaki,2 Kohji Hashiguchi,2 Takaya Ikeda,1 Hiroyuki Yamaguchi,1 Katsumi Nakatomi,1 Kazuto Ashizawa,3 Hiroshi Mukae1 1Department of Respiratory Medicine, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical...

Full description

Bibliographic Details
Main Authors: Shimada M, Fukuda M, Kitazaki T, Hashiguchi K, Ikeda T, Yamaguchi H, Nakatomi K, Ashizawa K, Mukae H
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:OncoTargets and Therapy
Subjects:
lung cancer
ALK
renal dysfunction
alectinib
Online Access:https://www.dovepress.com/adverse-renal-effects-of-anaplastic-lymphoma-kinase-inhibitors-and-the-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/adverse-renal-effects-of-anaplastic-lymphoma-kinase-inhibitors-and-the-peer-reviewed-article-OTT

Similar Items